PER RILASCIO IMMEDIATO:
CONTATTO:
David Clemente
Responsabile degli affari nordamericani
Centro di scelta dei consumatori
david@consumerchoicecenter.org
Il rifiuto del diritto di processare Bill è crudele e disumano
Washington DC – Yesterday, the House rejected a bill that would have given terminally ill patients the right to experimental medicines. The bill required 2/3rds support but failed to reach that mark having 259 vote in favor, and 140 vote in opposition. The majority of the opposition votes came from House Democrats, with Rep. Frank Pallone Jr stating “By defeating this bill tonight, we protected patients and supported F.D.A.’s continued role in approving experimental treatments that may help save a patient’s life”
The Consumer Choice Center condemns the rejection of “right to try” legislation and states that such prohibitions do nothing to protect terminally ill patients.
“Those who oppose the right to try, on patient protection grounds, fail to realize that we are talking about terminally ill patients. Denying those patients the right to try experimental drugs sentences them to succumb to their illness. To call that protecting patients is inhumane. Preventing a competent, consenting adult from taking a risk to save their life is both disgustingly paternalistic and incredibly cruel” David Clement, North American Affairs Manager for the Consumer Choice Center
***CCC North America Affairs Manager David Clement is available to speak with accredited media on consumer regulations and patient choice issues. Please send media inquiries QUI.***
—
Il CCC rappresenta i consumatori in oltre 100 paesi in tutto il mondo. Monitoriamo da vicino le tendenze normative a Ottawa, Washington, Bruxelles, Ginevra e altri punti caldi della regolamentazione e informiamo e attiviamo i consumatori a lottare per #ConsumerChoice. Ulteriori informazioni su consumerchoicecenter.org.
- Chi siamo
- Media
- Ricerca
- Aree politiche
- Eventi
- Eventi passati
- Il percorso da seguire: democrazie liberali e politica tecnologica
- Affrontare l'incertezza in un mondo post-pandemico
- Mentolo Melee della FDA: una sessione CCC
- CONCLAVE DI CANNABIS DEL CONSUMER CHOICE CENTER®
- Cannabis Conclave 2020
- Cannabis Conclave 2019
- Vertice sull'innovazione dei media e delle telecomunicazioni
- Giornata della libertà di marca
- Tavole rotonde sui media: l'OMS agisce
nell'interesse della salute pubblica globale?
- Eventi passati
- Donare